Four novel mutations identification in 17 beta-hydroxysteroid dehydrogenase-3 deficiency and our clinical experience: possible benefits of early treatment

IntroductionIndividuals with 17-beta-hydroxysteroid dehydrogenase type 3 (17β-HSD3) deficiency face a multitude of challenges, primarily concerning genital appearance, potential malignancy risks, and fertility issues. This study reports our findings from an investigation involving five individuals a...

Täydet tiedot

Bibliografiset tiedot

Päätekijät:	Yunpeng Wang, Yu Xu, Huijiao Zhang, Danyang Yin, Yiming Pan, Xiwen He, Shuaiting Li, Zhi Cheng, Gaohui Zhu, Ting Zhao, Huizhe Huang, Min Zhu
Aineistotyyppi:	Artigo
Kieli:	Inglês
Julkaistu:	Frontiers Media S.A. 2024-02-01
Sarja:	Frontiers in Endocrinology
Aiheet:	17β-HSD3 deficiency HSD17B3 mutation malignancy risk androgen testosterone
Linkit:	https://www.frontiersin.org/articles/10.3389/fendo.2023.1267967/full
Tagit:	Lisää tagi Ei tageja, Lisää ensimmäinen tagi!